Literature DB >> 12672219

Patient perspective in outcome assessments--perceptions or something more?

Tore K Kvien1, Turid Heiberg.   

Abstract

Health status measures constitute an essential part of outcome assessments in patients with rheumatic diseases. Currently used health status measures typically assess patient perceptions within various dimensions of health. The issue of widening patient perspective in outcome assessments was raised at OMERACT 2000 and further activities were initiated at the subsequent American College of Rheumatology meetings. Measuring patient perceptions of health is considered the standard approach in clinical practice, controlled clinical trials, and longitudinal observation studies, as well as in other types of epidemiological research. However, the traditionally used instruments also have limitations based on the relevance of the questionnaire items, sensitivity to change in longitudinal observational studies, and intraindividual variations over time. Patient priorities or preferences for improvement in health may be an alternative for the assessment of important patient outcomes. Data support that patient priorities for improvement in health are associated with their perception, but that overlap is incomplete and that complimentary information may be achieved. Expectations about future health and satisfaction with health may also represent alternative approaches. Thus, an open research agenda is required for the future, including different approaches regarding both endpoints and methodological issues.

Entities:  

Mesh:

Year:  2003        PMID: 12672219

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  18 in total

1.  Patients' perceptions of health related quality of life in rheumatoid arthritis and chronic low back pain.

Authors:  Montserrat Núñez; Alex Sanchez; Esther Nuñez; Teresa Casals; Cayetano Alegre; José Muñoz-Gomez
Journal:  Qual Life Res       Date:  2006-02       Impact factor: 4.147

2.  Patients' perceptions of health-related quality of life in rheumatoid arthritis.

Authors:  Montserrat Núñez; Esther Núñez; Alex Sanchez; José Luis del Val; María Bonet; Daniel Roig; Dolors Muñoz
Journal:  Clin Rheumatol       Date:  2009-06-27       Impact factor: 2.980

3.  Patient and public involvement in patient-reported outcome measures: evolution not revolution.

Authors:  Sophie Staniszewska; Kirstie L Haywood; Jo Brett; Liz Tutton
Journal:  Patient       Date:  2012       Impact factor: 3.883

4.  Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group.

Authors:  Jennifer Petkovic; Jennifer L Barton; Caroline Flurey; Niti Goel; Christie M Bartels; Cheryl Barnabe; Maarten P T de Wit; Anne Lyddiatt; Diane Lacaille; Vivian Welch; Annelies Boonen; Beverley Shea; Robin Christensen; Lara J Maxwell; Willemina Campbell; Janet Jull; Karine Toupin-April; Jasvinder A Singh; Charles H Goldsmith; Antoine G Sreih; Christoph Pohl; Catherine Hofstetter; Dorcas E Beaton; Rachelle Buchbinder; Francis Guillemin; Peter S Tugwell
Journal:  J Rheumatol       Date:  2017-02-15       Impact factor: 4.666

5.  Toward electronic health recording: evaluation of electronic patient reported outcome measures (e-PROMs) system for remote monitoring of early systemic lupus patients.

Authors:  Y El Miedany; M El Gaafary; Nadia El Aroussy; S Bahlas; M Hegazi; D Palmer; S Youssef
Journal:  Clin Rheumatol       Date:  2017-05-31       Impact factor: 2.980

6.  Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial.

Authors:  D van der Heijde; L Klareskog; A Singh; J Tornero; J Melo-Gomes; C Codreanu; R Pedersen; B Freundlich; S Fatenejad
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

Review 7.  [Clinical outcome measures in hand- and finger joint osteoarthritis from the patient perspective].

Authors:  T Stamm; K Machold; D Aletaha; G Stucki; J Smolen
Journal:  Z Rheumatol       Date:  2006-03       Impact factor: 1.372

8.  Relative importance of the functional abilities comprising Health Assessment Questionnaire Disability Index among rheumatoid arthritis patients.

Authors:  Risto Tuominen; Timo Möttönen; Carita Suominen; Tero Vahlberg; Sini Tuominen
Journal:  Rheumatol Int       Date:  2009-10-14       Impact factor: 2.631

9.  Measure of function in rheumatoid arthritis: individualised or classical scales?

Authors:  R Seror; F Tubach; G Baron; F Guillemin; P Ravaud
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

10.  Improved health outcomes with etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis.

Authors:  Sang-Cheol Bae; Suk Chyn Gun; Chi Chiu Mok; Rezaul Khandker; Henk W Nab; Andrew S Koenig; Bonnie Vlahos; Ron Pedersen; Amitabh Singh
Journal:  BMC Musculoskelet Disord       Date:  2013-01-08       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.